Dogan Vatansever

15PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersReproductionCancer therapy (excl. chemotherapy and radiation therapy)NeonatologyObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 30, 2026
Benchmarking Ultra-Low Attachment and Photopatterned GelMA 3D Culture Platforms for Modeling Cancer Stemness in High-Grade Serous Ovarian Cancer.

|Oct 24, 2025
Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lymphadenectomy in addition to bilateral pelvic SLN removal: Turkish Gynecologic Oncology Group (TRSGO-SLN-009).

Tugan Bese, Sait Sukru Cebi, Salih Taskin

|Nov 11, 2022
IVF characteristics and the molecular luteal features of random start IVF cycles are not different from conventional cycles in cancer patients.

Yashar Esmaeilian, Francesko Hela, Gamze Bildik

|Apr 16, 2021
Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer during COVID-19 pandemic.

Ali Ayhan, Safak Yilmaz Baran, Dogan Vatansever

|Mar 03, 2021
Impact of cytoreductive surgery on survival of patients with low-grade serous ovarian carcinoma: A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO-OvCa-001).

Dogan Vatansever, Cagatay Taskiran, Mehmet Mutlu Meydanli

|Feb 23, 2021
Is elective cancer surgery feasible during the lock-down period of the COVID-19 pandemic? Analysis of a single institutional experience of 404 consecutive patients.

Cemil Burak Kulle, Ibrahim Fethi Azamat, Dogan Vatansever

Pageof 3

Frequent Collaborators

7 joint publications

Cağatay Taşkıran

5 joint publications

Burak Giray

2 joint publications

Macit Arvas

2 joint publications

Salih Taskin